Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Cancer Network presents exclusive coverage of ESMO 2014 Congress

UBM Medica US announces that Cancer Network, a leading online community for oncologists and others who treat cancer and the online home of the journal ONCOLOGY, presents exclusive coverage of the European Society for Medical Oncology (ESMO) 2014 Congress, held September 26–30 in Madrid, Spain.

8 Oct 2014

GenomOncology, med fusion partner to optimize treatment strategies for tumor

med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a partnership to optimize treatment strategies based on the patient's disease state and tumor profile.

8 Oct 2014

C3BS inks preferred access agreement with Mayo Clinic

Cardio3 BioSciences, a leader in the discovery, development and commercialization of regenerative, protective and reconstructive therapies, announces today the signing of a preferred access agreement with Mayo Clinic.

8 Oct 2014

Wolters Kluwer Health wins 12 prizes at 2014 BMA Medical Book Awards

Wolters Kluwer Health, a leading global provider of information solutions for the healthcare provider and education markets, today announced that its Lippincott Williams & Wilkins textbooks and digital guides were honored with 12 prizes at the 2014 BMA Medical Book Awards.

8 Oct 2014

UCSD researchers define epidemiology of gastrointestinal stromal tumors

Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine.

8 Oct 2014

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.

8 Oct 2014

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines today announced that it has expanded its investor syndicate through the closing of a $6 million convertible note financing co-led by Fidelity Biosciences and TPG Biotech.

7 Oct 2014

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy.

7 Oct 2014

CleveXel Pharma receives license for two new oncology patents

CleveXel Pharma, a highly experienced pharmaceutical developer that conforms fully with global regulatory compliance, today announces that it has been granted a license by the SATT Sud Est, a technology transfer accelerator in South Eastern France (Societe d’Acceleration du Transfert de Technologies Sud Est), to exploit two patents.

7 Oct 2014

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

The introduction of antiretroviral drugs in Botswana over the last two decades has increased the life expectancies of people living with HIV—many of whom are women co-infected with the human papillomavirus virus (HPV)—considerably: from 39 years to the low 60s. As a result, this co-infected group of women is at a much higher risk of developing HPV-associated cervical cancer.

7 Oct 2014

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

Surgeon Teresa Rutledge, MD, recently received the National Cancer Institute's Cancer Clinical Investigator Team Leadership Award. Only 11 people nationwide received the award this year. Dr. Rutledge is the third faculty member in the history of the University of New Mexico Cancer Center to be recognized with this honor.

7 Oct 2014

New study finds geographic variation in use of laparoscopic colectomy for colon cancer patients

Where patients live in the country may determine whether they receive minimally invasive colon cancer surgery.

7 Oct 2014

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.

From NanoString Technologies 7 Oct 2014

Molecular breast imaging: an interview with Jim Calandra, CEO Gamma Medica

Studies have shown that mammograms fail to detect cancers in one-third to one-half of women with dense breasts (Clinical Literature on MBI). In some cases, the findings from a mammogram are inconclusive and secondary screening will almost always be required.

6 Oct 2014

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.

6 Oct 2014

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for PEGylated recombinant human hyaluronidase (PEGPH20) for the treatment of pancreatic cancer.

3 Oct 2014

Cultural, historical forces contribute to rise in cases of melanoma

A century's worth of cultural and historical forces have contributed to the rise in the incidence of melanoma, including changes in fashion and clothing design, according to an intriguing, retrospective research study conducted by investigators in the Ronald O. Perelman Department of Dermatology at NYU Langone Medical Center.

3 Oct 2014

Depression contributes to abnormal pain processes in IBS patients

High rates of anxiety and depression amongst patients with irritable bowel syndrome (IBS) have led many researchers to believe there could be a causal relationship between psychological factors and IBS symptoms. Now, scientists in Germany have found clear evidence that patients with IBS process pain signals from the gut abnormally, and that disturbed brain responses to pain are particularly pronounced in patients with more depression symptoms.

3 Oct 2014

Researchers identify biomarker that can predict GS7 prostate cancer patients

Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer.

3 Oct 2014

Ganymed, BioNTech AG open new headquarters and research facility in Germany

BioNTech AG and Ganymed Pharmaceuticals AG, two premier German biotechology companies, announced today the joint- opening of a new approx. 10,000 square-meters (108,000 square-feet) headquarters and research facility.

1 Oct 2014

Oncology News and Research

Further Reading

Cancer Network presents exclusive coverage of ESMO 2014 Congress

GenomOncology, med fusion partner to optimize treatment strategies for tumor

C3BS inks preferred access agreement with Mayo Clinic

Wolters Kluwer Health wins 12 prizes at 2014 BMA Medical Book Awards

UCSD researchers define epidemiology of gastrointestinal stromal tumors

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

CleveXel Pharma receives license for two new oncology patents

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

UNM Cancer Center surgeon receives NCI's Cancer Clinical Investigator Team Leadership Award

New study finds geographic variation in use of laparoscopic colectomy for colon cancer patients

NanoString, BWH partner to translate genomic biomarker discoveries into clinical cancer diagnostics

Molecular breast imaging: an interview with Jim Calandra, CEO Gamma Medica

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Halozyme's PEGPH20 receives FDA Orphan Drug designation for treatment of pancreatic cancer

Cultural, historical forces contribute to rise in cases of melanoma

Depression contributes to abnormal pain processes in IBS patients

Researchers identify biomarker that can predict GS7 prostate cancer patients

Ganymed, BioNTech AG open new headquarters and research facility in Germany

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News